Wellness & Recovery
Wellness and recovery programs are essential for those looking to restore strength and vitality after illness, injury, or the natural effects of aging. At JCRC-ABT CellGene Innovations, we offer regenerative therapies designed to speed up recovery, boost overall health, and provide rejuvenative care tailored to individual needs.
What Are Wellness & Recovery Programs?
Wellness and recovery focus on enhancing physical, mental, and emotional well-being following medical treatments, injuries, or age-related changes. These programs aim to rebuild strength, improve immunity, and support overall vitality.
Whether recovering from surgery, managing fatigue from chronic conditions, or seeking age-related rejuvenation, our personalized therapies offer a comprehensive solution. By combining cutting-edge regenerative medicine with holistic care, we help you achieve optimal health and long-term recovery.
Benefits of Our Treatments for Wellness & Recovery
Speeds Up Healing
MSC-based stem cell therapies aid in tissue repair and regeneration, helping patients recover faster from injuries or surgeries.
Enhances Immune Function
Immunotherapy strengthens immunity, making the body more resilient against future illnesses and promoting overall wellness.
Improves Energy and Vitality
Regenerative therapies reduce fatigue and enhance cellular function, restoring energy levels and physical strength.
Addresses Age-Related Concerns
Treatments like stem cell and gene therapies combat signs of aging by improving mobility, skin elasticity, and muscle strength.
Why Choose Us?
At JCRC-ABT CellGene Innovations, we provide personalized wellness and recovery plans that combine advanced therapies with compassionate care. Whether you’re rebuilding after a challenge or striving for peak health, we’re here to support you every step of the way.
1. Who can benefit from wellness and recovery programs?
Our programs are ideal for those recovering from illness or injury, dealing with chronic fatigue, or seeking age-related rejuvenation.
2. How long do wellness and recovery treatments take?
Treatment duration varies depending on individual goals, with some patients seeing results within weeks and others requiring several months for optimal recovery.
3. Are these therapies safe for older adults?
Yes, our treatments are minimally invasive and well-suited for patients of all ages, including seniors.
4. Can these programs help with post-treatment fatigue?
Absolutely. Our therapies are designed to rebuild strength, improve energy levels, and support overall recovery after intensive medical treatments.
5. Are lifestyle changes included in these programs?
Yes, we integrate lifestyle recommendations, such as nutrition and exercise, to maximize the benefits of your wellness and recovery plan.
Achievements
Case Studies
Acute Lymphoblastic Leukemia (ALL)
A study in Blood highlighted the success of CAR-T cell therapy (tisagenlecleucel) in pediatric and young adult patients with relapsed/refractory ALL. Over 80% achieved complete remission within one month of treatment, with sustained responses observed in more than 50% at 12 months.
Non-Small Cell Lung Cancer (NSCLC)
Research published in Nature showed that combining nivolumab (anti-PD-1) with ipilimumab (anti-CTLA-4) significantly improved progression-free survival in advanced NSCLC patients. The combination therapy demonstrated a 36% reduction in disease progression risk compared to chemotherapy.
Melanoma
A pivotal study in The New England Journal of Medicine demonstrated the efficacy of immune checkpoint inhibitors like pembrolizumab (anti-PD-1) in advanced melanoma. Patients experienced a 5-year overall survival rate of 43%, with durable tumor regression and manageable side effects, marking a breakthrough in melanoma treatment.
Cystic Fibrosis
A trial targeting CFTR gene mutations delivered via aerosolized vectors showed improved pulmonary function in patients with cystic fibrosis. Published in The Lancet Respiratory Medicine, the therapy reduced hospitalizations and improved quality of life metrics over 12 months.
Hemophilia B
Gene therapy using an AAV vector to deliver the FIX gene resulted in sustained Factor IX production in patients. A landmark study in Blood reported a significant reduction in bleeding episodes and factor replacement therapy use, lasting up to 5 years.
Leber’s Congenital Amaurosis (LCA)
The gene therapy Luxturna restored partial vision in patients with RPE65 gene mutations. Clinical trials demonstrated improved light sensitivity and navigation abilities, with effects persisting for over three years.
